Whitehawk Therapeutics (WHWK) Return on Sales (2018 - 2025)

Whitehawk Therapeutics (WHWK) has 7 years of Return on Sales data on file, last reported at 0.04% in Q4 2025.

• On a quarterly basis, Return on Sales fell 2.0% year-over-year to 0.04% in Q4 2025; TTM through Dec 2025 was 0.04%, a 2.0% decrease from a year earlier, with the FY2025 full-year figure at 0.02%, changed 0.0% from the prior year.
• Return on Sales for Q4 2025 stood at 0.04%, down from 0.01% in the prior quarter.
• Over the last five years, Return on Sales for WHWK reached as high as 0.1% in Q1 2025 and fell as low as 0.46% in Q1 2021.
• Historically, Return on Sales has averaged 0.04% across 5 years, with a median of 0.03% in 2022.
• On a YoY basis, Return on Sales climbed as much as 40 bps in 2022 and fell as far as 5 bps in 2022.
• Year by year, Return on Sales stood at 0.01% in 2021, then tumbled by 133 bps to 0.03% in 2022, then advanced by 3 bps to 0.03% in 2023, then increased by 17 bps to 0.02% in 2024, then tumbled by 95 bps to 0.04% in 2025.
• Per Business Quant data, the three most recent Return on Sales figures were 0.04% in Q4 2025, 0.01% in Q3 2025, and 0.0% in Q2 2025.